<DOC>
	<DOCNO>NCT01286402</DOCNO>
	<brief_summary>This study design gather preliminary effectiveness safety data use bupropion smoking cessation pregnant woman attend community prenatal clinic . This study provide critical preliminary data preparation large , Phase III clinical trial .</brief_summary>
	<brief_title>Double-blind , Placebo-Controlled Pilot Study Bupropion Promote Smoking Cessation During Pregnancy</brief_title>
	<detailed_description>A randomized , double-blind , parallel group design use allow rigorous preliminary assessment feasibility , effectiveness , safety bupropion SR ( sustained release ; package Zyban GlaxoSmithKline ) promote smoke cessation among woman second third trimester pregnancy . Fifty pregnant smoker randomize receive 8-week course either bupropion SR match placebo tablet . Both group receive evidence-based smoking cessation counseling . The primary smoking outcome 7-day point prevalence abstinence cotinine validation end treatment . Secondary outcome include enrollment , retention , compliance rate ; continuous abstinence end treatment 2 week followup ; continuous abstinence birth 2nd week postpartum followup ; self-reported reduction number cigarette smoke per day ; maternal side effect perinatal/neonatal outcome . Preliminary smoking cessation safety outcome assessed generation evidence-based hypothesis regard clinical benefit bupropion pregnant smoker preparation fo large trial .</detailed_description>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Pregnant woman ≥ 18 year age Gestational age 14 26 week confirm ultrasound Currently smoke ≥ 5 cigarette per day Abnormal liver function test History current seizure disorder close head injury loss consciousness Known hypersensitivity bupropion Any psychiatric disorder require psychotropic medication Current anorexia bulimia Use monoamine oxidase ( MAO ) inhibitor discontinuation within past 2 week Major Depressive Disorder current suicidal risk Use illicit substance since receive knowledge pregnancy Regular use alcohol ( &gt; 1 drink/week average ) Unstable medical problem , liver renal disease , uncontrollable hypertension , lupus Twins multiple gestation Fetal abnormality 14 week ultrasound Plans deliver hospital Memorial Hermann Inability communicate research staff make study visit due lack phone transportation access Participation another clinical study may affect study outcomes Current use Nicotine Replacement Therapy ( NRT ) , bupropion , varenicline ( Chantix )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Smoking cessation pregnancy</keyword>
	<keyword>bupropion</keyword>
</DOC>